Replies to post #163447 on Amarin Corp Plc (AMRN)

[Bouf]

Agree with all except the patents buyback. I have not read those deal docs, but I assume Amarin kept the right to pay off and buy back patents whenever it chooses to. The BO funds could be used to close on the payoff to Pharmakon. It can all be handled at the same time, just like paying off an existing mortgage on a house when it gets sold. So secondary proceeds can be used to create profit, not pay off debt.

[HDGabor]

D-

As of 9-30 Amarin had $30M of short term and $83M of long term debt-$113M total

Nope … the total was 94M (read the 10-Q)

Amrn sold the Vascepa patents to Pharmakon

Nope … the patents weren't sold. (Read the agreement.)

Best,
G